Kristóf Karlócai

Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension

Gérald Simonneau, Adam Torbicki, Marius M. Hoeper et al. · European Respiratory Journal · 2012 · 308 citations

RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Hossein Ardeschir Ghofrani, Gérald Simonneau, Andrea Maria D’Armini et al. · The Lancet Respiratory Medicine · 2017 · 262 citations

Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial

Roela Sadushi‐Kolici, Pavel Jansa, Grzegorz Kopeć et al. · The Lancet Respiratory Medicine · 2018 · 184 citations · Full text

Thrombosis, Pulmonary Embolism, Hypertension +9

Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension

Christian Gerges, Mario Gerges, Richard Friewald et al. · Circulation · 2020 · 75 citations · Full text

Effect of vasoactive drugs on carotid diameter in humans

Istvan Bonyhay, Gábor Jokkel, Kristóf Karlócai et al. · American Journal of Physiology-Heart and Circulatory Physiology · 1997 · 37 citations